Anlotinib Combined with Sintilimab As First-Line Treatment in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma (nccrr): Preliminary Results from an Exploratory Prospective Multicentre Clinical Study.
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined